Prevalence of neutralizing antibodies to Equine rhinitis A and B virus in horses and man

G. Kriegshäuser, A. Deutz, E. Kuechler, T. Skern, H. Lussy, N. Nowotny

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Equine rhinitis viruses (ERVs) are the causative agents of mild to severe upper respiratory infections in horses worldwide. Immunologically, four serotypes of ERVs have been identified. Equine rhinitis A virus (ERAV) and Equine rhinitis B virus 1 (ERBV1) are the most frequent serotypes in Europe. Both viruses have a broad host range in cultured cells with ERAV being able to infect humans. Since there is neither information on the seroprevalence of ERAV and ERBV1 in Austria nor on the zoonotic potential of ERBV1, we investigated 200 horse and 137 veterinary sera for the presence of neutralizing antibodies relating to ERAV and ERBV1. One hundred and eighty (90%) and 173 (86%) horse sera neutralized ERAV and ERBV1, respectively. In contrast, only four (2.7%) and five (3.6%) human sera showed weak neutralizing activity to ERAV and ERBV1, respectively. These results indicate that ERAV and ERBV1 are widespread in the Austrian horse population; however, the risk of acquiring zoonotic infection among veterinarians appears low.

Original languageEnglish
Pages (from-to)293-296
Number of pages4
JournalVeterinary Microbiology
Volume106
Issue number3-4
DOIs
Publication statusPublished - Apr 10 2005

Fingerprint

Erbovirus
Equine rhinitis B virus
Aphthovirus
Equine rhinitis A virus
Neutralizing Antibodies
neutralizing antibodies
Horses
horses
rhinitis
Zoonoses
Rhinitis
Viruses
viruses
serotypes
Serum
Veterinarians
Austria
Host Specificity
Seroepidemiologic Studies
neutralization

Keywords

  • Equine rhinitis virus
  • Neutralization
  • Seroprevalence
  • Zoonotic infection

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Microbiology
  • veterinary(all)

Cite this

Prevalence of neutralizing antibodies to Equine rhinitis A and B virus in horses and man. / Kriegshäuser, G.; Deutz, A.; Kuechler, E.; Skern, T.; Lussy, H.; Nowotny, N.

In: Veterinary Microbiology, Vol. 106, No. 3-4, 10.04.2005, p. 293-296.

Research output: Contribution to journalArticle

Kriegshäuser, G. ; Deutz, A. ; Kuechler, E. ; Skern, T. ; Lussy, H. ; Nowotny, N. / Prevalence of neutralizing antibodies to Equine rhinitis A and B virus in horses and man. In: Veterinary Microbiology. 2005 ; Vol. 106, No. 3-4. pp. 293-296.
@article{b0fd70becc4946eb907c27563bcd02f5,
title = "Prevalence of neutralizing antibodies to Equine rhinitis A and B virus in horses and man",
abstract = "Equine rhinitis viruses (ERVs) are the causative agents of mild to severe upper respiratory infections in horses worldwide. Immunologically, four serotypes of ERVs have been identified. Equine rhinitis A virus (ERAV) and Equine rhinitis B virus 1 (ERBV1) are the most frequent serotypes in Europe. Both viruses have a broad host range in cultured cells with ERAV being able to infect humans. Since there is neither information on the seroprevalence of ERAV and ERBV1 in Austria nor on the zoonotic potential of ERBV1, we investigated 200 horse and 137 veterinary sera for the presence of neutralizing antibodies relating to ERAV and ERBV1. One hundred and eighty (90{\%}) and 173 (86{\%}) horse sera neutralized ERAV and ERBV1, respectively. In contrast, only four (2.7{\%}) and five (3.6{\%}) human sera showed weak neutralizing activity to ERAV and ERBV1, respectively. These results indicate that ERAV and ERBV1 are widespread in the Austrian horse population; however, the risk of acquiring zoonotic infection among veterinarians appears low.",
keywords = "Equine rhinitis virus, Neutralization, Seroprevalence, Zoonotic infection",
author = "G. Kriegsh{\"a}user and A. Deutz and E. Kuechler and T. Skern and H. Lussy and N. Nowotny",
year = "2005",
month = "4",
day = "10",
doi = "10.1016/j.vetmic.2004.12.029",
language = "English",
volume = "106",
pages = "293--296",
journal = "Veterinary Microbiology",
issn = "0378-1135",
publisher = "Elsevier",
number = "3-4",

}

TY - JOUR

T1 - Prevalence of neutralizing antibodies to Equine rhinitis A and B virus in horses and man

AU - Kriegshäuser, G.

AU - Deutz, A.

AU - Kuechler, E.

AU - Skern, T.

AU - Lussy, H.

AU - Nowotny, N.

PY - 2005/4/10

Y1 - 2005/4/10

N2 - Equine rhinitis viruses (ERVs) are the causative agents of mild to severe upper respiratory infections in horses worldwide. Immunologically, four serotypes of ERVs have been identified. Equine rhinitis A virus (ERAV) and Equine rhinitis B virus 1 (ERBV1) are the most frequent serotypes in Europe. Both viruses have a broad host range in cultured cells with ERAV being able to infect humans. Since there is neither information on the seroprevalence of ERAV and ERBV1 in Austria nor on the zoonotic potential of ERBV1, we investigated 200 horse and 137 veterinary sera for the presence of neutralizing antibodies relating to ERAV and ERBV1. One hundred and eighty (90%) and 173 (86%) horse sera neutralized ERAV and ERBV1, respectively. In contrast, only four (2.7%) and five (3.6%) human sera showed weak neutralizing activity to ERAV and ERBV1, respectively. These results indicate that ERAV and ERBV1 are widespread in the Austrian horse population; however, the risk of acquiring zoonotic infection among veterinarians appears low.

AB - Equine rhinitis viruses (ERVs) are the causative agents of mild to severe upper respiratory infections in horses worldwide. Immunologically, four serotypes of ERVs have been identified. Equine rhinitis A virus (ERAV) and Equine rhinitis B virus 1 (ERBV1) are the most frequent serotypes in Europe. Both viruses have a broad host range in cultured cells with ERAV being able to infect humans. Since there is neither information on the seroprevalence of ERAV and ERBV1 in Austria nor on the zoonotic potential of ERBV1, we investigated 200 horse and 137 veterinary sera for the presence of neutralizing antibodies relating to ERAV and ERBV1. One hundred and eighty (90%) and 173 (86%) horse sera neutralized ERAV and ERBV1, respectively. In contrast, only four (2.7%) and five (3.6%) human sera showed weak neutralizing activity to ERAV and ERBV1, respectively. These results indicate that ERAV and ERBV1 are widespread in the Austrian horse population; however, the risk of acquiring zoonotic infection among veterinarians appears low.

KW - Equine rhinitis virus

KW - Neutralization

KW - Seroprevalence

KW - Zoonotic infection

UR - http://www.scopus.com/inward/record.url?scp=15044346105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15044346105&partnerID=8YFLogxK

U2 - 10.1016/j.vetmic.2004.12.029

DO - 10.1016/j.vetmic.2004.12.029

M3 - Article

VL - 106

SP - 293

EP - 296

JO - Veterinary Microbiology

JF - Veterinary Microbiology

SN - 0378-1135

IS - 3-4

ER -